ContraFect Corporation (NASDAQ:CFRX) released its quarterly earnings results on Wednesday. The biotechnology company reported ($0.07) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.18) by $0.11, Bloomberg Earnings reports.

ContraFect Corporation (NASDAQ CFRX) remained flat at $1.25 during midday trading on Thursday. The company had a trading volume of 42,576 shares. The company’s market cap is $52.07 million. ContraFect Corporation has a 12 month low of $1.10 and a 12 month high of $3.28. The firm’s 50-day moving average price is $1.34 and its 200-day moving average price is $1.62.

ILLEGAL ACTIVITY WARNING: “ContraFect Corporation (NASDAQ:CFRX) Posts Quarterly Earnings Results, Beats Expectations By $0.11 EPS” was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this piece of content can be accessed at

In other ContraFect Corporation news, Director Sol J. Barer acquired 40,000 shares of the business’s stock in a transaction dated Tuesday, July 25th. The stock was acquired at an average cost of $1.24 per share, for a total transaction of $49,600.00. Following the completion of the transaction, the director now directly owns 815,933 shares of the company’s stock, valued at $1,011,756.92. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders bought 50,800 shares of company stock valued at $62,992 over the last 90 days. Company insiders own 9.30% of the company’s stock.

Separately, Maxim Group reissued a “hold” rating on shares of ContraFect Corporation in a report on Wednesday, April 19th.

Earnings History for ContraFect Corporation (NASDAQ:CFRX)

Receive News & Ratings for ContraFect Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ContraFect Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.